The excitatory-inhibitory balance as a target for the development of novel drugs to treat schizophrenia (2024)
- Authors:
- USP affiliated authors: GOMES, FELIPE VILLELA - FMRP ; LISBÔA, JOÃO ROBERTO FERNANDES - FMRP
- Unidade: FMRP
- DOI: 10.1016/j.bcp.2024.116298
- Subjects: NEURÔNIOS; FÁRMACOS; FARMACOLOGIA; NEUROTRANSMISSORES; NEURÔNIOS
- Keywords: Schizophrenia; Excitatory-inhibitory balance; PV interneuron
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2024
- Source:
- Título: Biochemical Pharmacology
- ISSN: 0006-2952
- Volume/Número/Paginação/Ano: v. 228, art. 116298, p. 1-13, 2024
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
ULIANA, Daniela L. et al. The excitatory-inhibitory balance as a target for the development of novel drugs to treat schizophrenia. Biochemical Pharmacology, v. 228, p. 1-13, 2024Tradução . . Disponível em: https://doi.org/10.1016/j.bcp.2024.116298. Acesso em: 23 jan. 2026. -
APA
Uliana, D. L., Lisboa, J. R. F., Gomes, F. V., & Grace, A. A. (2024). The excitatory-inhibitory balance as a target for the development of novel drugs to treat schizophrenia. Biochemical Pharmacology, 228, 1-13. doi:10.1016/j.bcp.2024.116298 -
NLM
Uliana DL, Lisboa JRF, Gomes FV, Grace AA. The excitatory-inhibitory balance as a target for the development of novel drugs to treat schizophrenia [Internet]. Biochemical Pharmacology. 2024 ; 228 1-13.[citado 2026 jan. 23 ] Available from: https://doi.org/10.1016/j.bcp.2024.116298 -
Vancouver
Uliana DL, Lisboa JRF, Gomes FV, Grace AA. The excitatory-inhibitory balance as a target for the development of novel drugs to treat schizophrenia [Internet]. Biochemical Pharmacology. 2024 ; 228 1-13.[citado 2026 jan. 23 ] Available from: https://doi.org/10.1016/j.bcp.2024.116298 - MMP-9 as a marker for the association between childhood/adolescent trauma and psychosis
- Perineuronal net density in schizophrenia: a systematic review of postmortem brain studies
- Stress during critical periods of development and risk for schizophrenia
- Altered ventral striatum–hippocampus connectivity during reward processing as an endophenotype for psychosis
- Molecular findings guiding the modulation of the endocannabinoid system as a potential target to treat schizophrenia
- Tratamento repetido com canabidiol atenua alterações comportamentais e moleculares em um modelo de esquizofrenia baseado no antagonismo dos receptores NMDA
- Cortical dopamine dysregulation in schizophrenia and its link to stress. [Carta]
- Stress impacts corticoamygdalar connectivity in an age-dependent manner
- The pathophysiological impact of stress on the dopamine system is dependent on the state of the critical period of vulnerability
- Dysregulation of midbrain dopamine system and the pathophysiology of schizophrenia
Informações sobre o DOI: 10.1016/j.bcp.2024.116298 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
